BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fatima K, Mathew S, Suhail M, Ali A, Damanhouri G, Azhar E, Qadri I. Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. PLoS One 2014;9:e106339. [PMID: 25188400 DOI: 10.1371/journal.pone.0106339] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Khalil A, Tazeddinova D, Aljoumaa K, Kazhmukhanbetkyzy ZA, Orazov A, Toshev AD. Carotenoids: Therapeutic Strategy in the Battle against Viral Emerging Diseases, COVID-19: An Overview. Prev Nutr Food Sci 2021;26:241-61. [PMID: 34737985 DOI: 10.3746/pnf.2021.26.3.241] [Reference Citation Analysis]
2 Nakano S, Megro SI, Hase T, Suzuki T, Isemura M, Nakamura Y, Ito S. Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies. Molecules 2018;23:E2020. [PMID: 30104534 DOI: 10.3390/molecules23082020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
3 Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. Hepatitis C virus and neurological damage. World J Hepatol 2016; 8(12): 545-556 [PMID: 27134702 DOI: 10.4254/wjh.v8.i12.545] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
4 Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections. Arch Virol 2017;162:2539-51. [PMID: 28547385 DOI: 10.1007/s00705-017-3417-y] [Cited by in Crossref: 126] [Cited by in F6Publishing: 101] [Article Influence: 25.2] [Reference Citation Analysis]
5 Devnarain N, Soliman ME. Molecular mechanism of resveratrol inhibition of Zika virus NS3 helicase: behind the scenes. Future Virology 2019;14:73-84. [DOI: 10.2217/fvl-2018-0170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Song JM. Anti-infective potential of catechins and their derivatives against viral hepatitis. Clin Exp Vaccine Res 2018;7:37-42. [PMID: 29399578 DOI: 10.7774/cevr.2018.7.1.37] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
7 Petit L, Vernès L, Cadoret JP. Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2. J Appl Phycol 2021;:1-24. [PMID: 33776210 DOI: 10.1007/s10811-021-02372-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Séron K, Sahuc M, Rouillé Y. Natural Products and Hepatitis C Virus. In: Mérillon J, Riviere C, editors. Natural Antimicrobial Agents. Cham: Springer International Publishing; 2018. pp. 289-327. [DOI: 10.1007/978-3-319-67045-4_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Agrawal PK, Agrawal C, Blunden G. Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations. Natural Product Communications 2020;15:1934578X2097629. [DOI: 10.1177/1934578x20976293] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Quintero-Gil C, Parra-Suescún J, Lopez-Herrera A, Orduz S. In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein. Virusdisease 2017;28:281-8. [PMID: 29291214 DOI: 10.1007/s13337-017-0383-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]